$EXPO
EXPONENT INC

2016 Q3 Form 10-Q Financial Statement

#000114420416131513 Filed on November 04, 2016

View on sec.gov

Income Statement

Concept 2016 Q3 2016 Q1 2015 Q4
Revenue $77.61M $73.68M $78.99M
YoY Change -2.82% 0.1% 0.56%
Cost Of Revenue $4.000M $3.900M $4.500M
YoY Change -13.04% -2.5% 4.65%
Gross Profit $73.30M $69.80M $74.50M
YoY Change -2.66% 0.29% 0.27%
Gross Profit Margin 94.44% 94.73% 94.31%
Selling, General & Admin $51.20M $48.50M $46.80M
YoY Change 2.61% -0.41% -3.11%
% of Gross Profit 69.85% 69.48% 62.82%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.500M $1.500M $1.300M
YoY Change 15.38% 7.14% -7.14%
% of Gross Profit 2.05% 2.15% 1.74%
Operating Expenses $62.02M $55.50M $58.07M
YoY Change 1.4% 0.0% -2.1%
Operating Profit $15.60M $14.28M $20.92M
YoY Change -16.63% 1.03% 8.75%
Interest Expense $200.0K $100.0K $0.00
YoY Change
% of Operating Profit 1.28% 0.7% 0.0%
Other Income/Expense, Net $2.325M $1.600M -$2.148M
YoY Change 296.08% -5.88% 148.9%
Pretax Income $17.92M $16.00M $18.77M
YoY Change -7.11% 1.07% 2.17%
Income Tax $6.631M $6.100M $7.054M
% Of Pretax Income 37.0% 38.13% 37.58%
Net Earnings $11.29M $9.850M $11.72M
YoY Change -3.49% 6.57% 6.15%
Net Earnings / Revenue 14.55% 13.37% 14.84%
Basic Earnings Per Share $0.43 $0.37 $0.44
Diluted Earnings Per Share $0.42 $0.36 $0.43
COMMON SHARES
Basic Shares Outstanding 26.55M shares 26.49M shares 26.60M shares
Diluted Shares Outstanding 27.19M shares 27.13M shares 27.27M shares

Balance Sheet

Concept 2016 Q3 2016 Q1 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $162.1M $171.6M $151.3M
YoY Change 8.14% 11.14% 6.85%
Cash & Equivalents $98.43M $125.8M $124.5M
Short-Term Investments $48.50M $45.80M $26.80M
Other Short-Term Assets $18.20M $12.60M $24.00M
YoY Change -29.18% -14.29% 1.27%
Inventory
Prepaid Expenses
Receivables $94.29M $88.58M $94.20M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $257.3M $272.8M $269.5M
YoY Change -4.38% 2.36% 5.89%
LONG-TERM ASSETS
Property, Plant & Equipment $37.46M $28.49M $29.40M
YoY Change 36.21% 0.78% 2.08%
Goodwill $8.607M $8.607M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $929.0K $1.651M $61.50M
YoY Change -98.52% 47.28% 2.16%
Total Long-Term Assets $128.1M $114.7M $99.50M
YoY Change 29.4% 16.12% 1.99%
TOTAL ASSETS
Total Short-Term Assets $257.3M $272.8M $269.5M
Total Long-Term Assets $128.1M $114.7M $99.50M
Total Assets $385.4M $387.5M $369.0M
YoY Change 4.7% 6.08% 4.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.700M $3.622M $8.900M
YoY Change -10.31% 62.42% -19.09%
Accrued Expenses $47.50M $6.958M $54.70M
YoY Change -2.86% 3.77% 0.37%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $69.17M $80.47M $69.60M
YoY Change 7.23% 1.42% -2.46%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.102M $1.913M $42.60M
YoY Change -95.22% 2.74% 2541.04%
Total Long-Term Liabilities $2.102M $1.913M $42.60M
YoY Change -95.22% 2.74% 2541.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $69.17M $80.47M $69.60M
Total Long-Term Liabilities $2.102M $1.913M $42.60M
Total Liabilities $118.6M $124.7M $112.2M
YoY Change 9.3% 3.05% 0.62%
SHAREHOLDERS EQUITY
Retained Earnings $285.6M $269.3M
YoY Change 11.7% 9.03%
Common Stock $193.1M $179.8M
YoY Change 12.24%
Preferred Stock
YoY Change
Treasury Stock (at cost) $209.5M $184.5M
YoY Change 23.05% 13.88%
Treasury Stock Shares 7.261M shares 7.133M shares 7.172M shares
Shareholders Equity $266.8M $262.8M $256.8M
YoY Change
Total Liabilities & Shareholders Equity $385.4M $387.5M $369.0M
YoY Change 4.71% 6.08% 4.81%

Cashflow Statement

Concept 2016 Q3 2016 Q1 2015 Q4
OPERATING ACTIVITIES
Net Income $11.29M $9.850M $11.72M
YoY Change -3.49% 6.57% 6.15%
Depreciation, Depletion And Amortization $1.500M $1.500M $1.300M
YoY Change 15.38% 7.14% -7.14%
Cash From Operating Activities $14.20M $26.20M $19.50M
YoY Change 8.4% 18.02% 26.62%
INVESTING ACTIVITIES
Capital Expenditures $9.681M -$1.000M $2.641M
YoY Change 790.62% 0.0% 36.84%
Acquisitions
YoY Change
Other Investing Activities $8.000M -$19.30M -$9.000M
YoY Change 142.42% -2244.44% -266.67%
Cash From Investing Activities $6.100M -$20.20M -$11.60M
YoY Change 190.48% 10000.0% -431.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.000M -4.500M -15.20M
YoY Change -29.58% -40.0% 1.33%
NET CHANGE
Cash From Operating Activities 14.20M 26.20M 19.50M
Cash From Investing Activities 6.100M -20.20M -11.60M
Cash From Financing Activities -5.000M -4.500M -15.20M
Net Change In Cash 15.30M 1.500M -7.300M
YoY Change 88.89% -89.66% -287.18%
FREE CASH FLOW
Cash From Operating Activities $14.20M $26.20M $19.50M
Capital Expenditures $9.681M -$1.000M $2.641M
Free Cash Flow $4.519M $27.20M $16.86M
YoY Change -62.38% 17.24% 25.16%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
21221000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
19979000 USD
us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
11619000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
226444000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
225916000 USD
us-gaap Reimbursement Revenue
ReimbursementRevenue
11619000 USD
us-gaap Reimbursement Revenue
ReimbursementRevenue
13235000 USD
us-gaap Revenues
Revenues
238063000 USD
us-gaap Revenues
Revenues
239151000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
146854000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
139745000 USD
us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
13235000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11407000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11538000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
46962000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
54654000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
489000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
115000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4880000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
367000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
52331000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
55136000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15239000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21387000 USD
us-gaap Net Income Loss
NetIncomeLoss
37092000 USD
us-gaap Net Income Loss
NetIncomeLoss
33749000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.4
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.23
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26563000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26644000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27234000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27350000 shares
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.54
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
us-gaap Operating Expenses
OperatingExpenses
191101000 USD
us-gaap Operating Expenses
OperatingExpenses
184497000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5369000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
482000 USD
CY2016Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
74160000 USD
CY2015Q4 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
74503000 USD
CY2016Q3 us-gaap Reimbursement Revenue
ReimbursementRevenue
3452000 USD
CY2015Q4 us-gaap Reimbursement Revenue
ReimbursementRevenue
4491000 USD
CY2016Q3 us-gaap Revenues
Revenues
77612000 USD
CY2016Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
47797000 USD
CY2015Q4 us-gaap Labor And Related Expense
LaborAndRelatedExpense
42853000 USD
CY2016Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
7020000 USD
CY2015Q4 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6766000 USD
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Trading Symbol
TradingSymbol
EXPO
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25592534 shares
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
65000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4000 USD
CY2016Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-19000 USD
CY2015Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
13000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13063000 USD
CY2015Q4 us-gaap Revenues
Revenues
78994000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-7000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-515000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-696000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-535000 USD
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11084000 USD
CY2015Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11533000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4509000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4034000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-330000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-80000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1688000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
785000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
10659000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
10536000 USD
CY2016Q3 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
3452000 USD
CY2015Q4 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
4491000 USD
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3748000 USD
CY2015Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3963000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
15595000 USD
CY2016Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
88577000 USD
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
20921000 USD
CY2016Q3 us-gaap Investment Income Net
InvestmentIncomeNet
179000 USD
CY2015Q4 us-gaap Investment Income Net
InvestmentIncomeNet
47000 USD
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2146000 USD
CY2015Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2195000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
17920000 USD
CY2015Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
18773000 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6631000 USD
CY2015Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7054000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
11289000 USD
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
11719000 USD
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26545000 shares
CY2015Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26597000 shares
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27185000 shares
CY2015Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27268000 shares
CY2016Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.18
CY2015Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
62017000 USD
CY2015Q4 us-gaap Operating Expenses
OperatingExpenses
58073000 USD
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2325000 USD
CY2015Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2148000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
125751000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98425000 USD
CY2016Q1 us-gaap Short Term Investments
ShortTermInvestments
45842000 USD
CY2016Q3 us-gaap Short Term Investments
ShortTermInvestments
51993000 USD
CY2016Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
94292000 USD
CY2016Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12616000 USD
CY2016Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12596000 USD
CY2016Q1 us-gaap Assets Current
AssetsCurrent
272786000 USD
CY2016Q3 us-gaap Assets Current
AssetsCurrent
257306000 USD
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28485000 USD
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
37457000 USD
CY2016Q1 us-gaap Goodwill
Goodwill
8607000 USD
CY2016Q3 us-gaap Goodwill
Goodwill
8607000 USD
CY2016Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
39456000 USD
CY2016Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
40751000 USD
CY2016Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
36522000 USD
CY2016Q3 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
40365000 USD
CY2016Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1651000 USD
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
929000 USD
CY2016Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10580000 USD
CY2016Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9709000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2334000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
13555000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8585000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2212000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
29950000 USD
CY2016Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
62092000 USD
CY2016Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
53866000 USD
CY2016Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
7802000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1284000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-869000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7403000 USD
CY2016Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5590000 USD
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
80474000 USD
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
69165000 USD
CY2016Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1913000 USD
CY2016Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2102000 USD
CY2016Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
40322000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
33210000 USD
CY2016Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-186000 USD
CY2015Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-199000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
4983000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
19814000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-32429000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-631000 USD
CY2016Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
45662000 USD
CY2016Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1994000 USD
CY2016Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1664000 USD
CY2016Q1 us-gaap Liabilities
Liabilities
124703000 USD
CY2016Q3 us-gaap Liabilities
Liabilities
118593000 USD
CY2016Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
179816000 USD
CY2016Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
193105000 USD
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
269259000 USD
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
285616000 USD
CY2016Q1 us-gaap Treasury Stock Value
TreasuryStockValue
184499000 USD
CY2016Q3 us-gaap Treasury Stock Value
TreasuryStockValue
209496000 USD
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
262804000 USD
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
266822000 USD
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 USD
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-65000 USD
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-2436000 USD
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-1740000 USD
CY2016Q3 us-gaap Assets
Assets
385415000 USD
CY2016Q1 us-gaap Assets
Assets
387507000 USD
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
385415000 USD
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
387507000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
36461000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-114000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-27326000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5033000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
129490000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
124457000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
28901000 USD
CY2016Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
127442000 USD
CY2016Q3 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
51845000 USD
CY2016Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
51845000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
10530000 USD
CY2016Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
99312000 USD
CY2016Q1 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
46740000 USD
CY2016Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
46740000 USD
CY2016Q3 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearOne
7994000 USD
CY2016Q3 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearTwo
44000000 USD
CY2016Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
51994000 USD
CY2016Q3 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearOne
8003000 USD
CY2016Q3 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearTwo
43990000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
342000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1206000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1059000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4236000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-4091000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3900000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
37234000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
34310000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4355000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-19113000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-6800000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4983000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7685000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7365000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
24456000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1499000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1547000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
14174000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
11780000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-44816000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
36000000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
16000000 USD
us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
4943000 USD
CY2014Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
CY2015Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
491312 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
463402 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
19814000 USD
CY2016Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
22307000 USD
us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
5791000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
13375000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
17087000 USD
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
6334000 USD
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
6169000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
739000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
805000 USD
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
33000 USD
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
33000 USD
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2436000 USD
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1805000 USD
CY2016Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3805000 USD
CY2016Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2792000 USD
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32853000 shares
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32853000 shares
CY2016Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
7261000 shares
CY2016Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
7133000 shares
CY2016Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
150419000 USD
CY2016Q3 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
14000 USD
CY2016Q3 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
15000 USD
CY2016Q3 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
150418000 USD
CY2016Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
171699000 USD
CY2016Q1 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
1000 USD
CY2016Q1 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
107000 USD
CY2016Q1 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
171593000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
0 USD
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
24456000 USD
CY2016Q3 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
1458000 USD
CY2015Q4 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
-2688000 USD
expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
2823000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2016Q3 expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure
CY2016Q3 expo Entity Wide Account Receivable Major Customer Percentage
EntityWideAccountReceivableMajorCustomerPercentage
0.1 pure
CY2015Q4 expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure
CY2016Q1 expo Entity Wide Account Receivable Major Customer Percentage
EntityWideAccountReceivableMajorCustomerPercentage
0.1 pure
expo Share Based Compensation Arrangements By Share Based Payment Award Options Expiration Term
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm
P10Y
CY2016Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1582000 USD
CY2015Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1329000 USD
CY2016Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
CY2016Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
CY2016Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
CY2016Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4628000 USD
CY2016Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4675000 USD
CY2016Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4659000 USD
CY2015Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2016Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2016 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.60
CY2015Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3870000 USD
CY2016Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3867000 USD
CY2016 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
15482000 USD
CY2015Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2015Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3887000 USD
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.54
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
13962000 USD
CY2015Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2015Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3858000 USD
expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
-1379000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Use of Estimates. <font style="FONT-WEIGHT: normal">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include accounting for revenue recognition and estimating the allowance for contract losses and doubtful accounts. Actual results could differ from those estimates.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

Files In Submission

Name View Source Status
0001144204-16-131513-index-headers.html Edgar Link pending
0001144204-16-131513-index.html Edgar Link pending
0001144204-16-131513.txt Edgar Link pending
0001144204-16-131513-xbrl.zip Edgar Link pending
expo-20160930.xml Edgar Link completed
expo-20160930.xsd Edgar Link pending
expo-20160930_cal.xml Edgar Link unprocessable
expo-20160930_def.xml Edgar Link unprocessable
expo-20160930_lab.xml Edgar Link unprocessable
expo-20160930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v450900_10q.htm Edgar Link pending
v450900_ex10-46.htm Edgar Link pending
v450900_ex31-1.htm Edgar Link pending
v450900_ex31-2.htm Edgar Link pending
v450900_ex32-1.htm Edgar Link pending
v450900_ex32-2.htm Edgar Link pending